James McCracken, MD

James T. McCracken, MD is a nationally recognized expert in child and adolescent psychiatry with particular expertise in the pharmacologic treatment of neurodevelopmental disorders, including ADHD, autism spectrum disorder, obsessive-compulsive disorder, and tic disorders. His research has been pioneering in the field of pharmacogenetics, focusing on how genetic variation influences treatment response to psychiatric medications in children and adolescents.

Dr. McCracken has led numerous large-scale, federally funded studies aimed at developing and optimizing treatments for autism and related conditions. A highly influential researcher and mentor, he has received multiple national awards for his contributions to child psychiatry and continues to shape clinical practice and research through his scholarship and leadership.